Copy to clipboard 
CMDC Labs, a provider of analytical testing and consulting services, received an expanded ISO 17025 certification that now covers additional protocols, including ISO 11737, ISO 22196, USP<61>, AATCC TM100 and AATCC TM147.
The addition of these protocols to CMDC Labs’ ISO 17025 certification is a testament to the company’s commitment to providing the highest quality analytical testing services to its clients.
ISO 11737 and ISO 22196 are standards that define methods for evaluating the bioburden and antibacterial properties of medical devices and surfaces, respectively. USP<61> is a standard for microbial enumeration testing of non-sterile products, while AATCC TM100 and AATCC TM147 are standards for evaluating the antimicrobial efficacy of textiles.
“Expanding our ISO 17025 certification to cover these additional protocols is a significant achievement for CMDC Labs,” said Dan Storey, CEO of CMDC Labs. “This certification further demonstrates our commitment to providing our clients with the highest quality testing services possible. We are proud to be able to offer our clients a wide range of testing capabilities that meet the most stringent industry standards.”
CMDC Labs is a full-service analytical testing and consulting company that offers a wide range of testing services to clients in the medical device, biotechnology and other industries. Some of the assays CMDC’s biotechnology testing laboratory performs include:
- Medical device and biomaterial surface cellular and biological activity bioassays
- Medical device coating and biomaterial coating surface cellular and biological activity bioassays
- Comparability, lot-release and stability bioassays
- Clinical sample analysis/studies, pre-clinical sample analysis/studies, sample testing and analyses
Source: CMDC Labs
